By Steve Moore | Thursday 7 September 2023
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Previously writing on Polarean Imaging (POLX), a medical imaging company which emphasises it has “developed the first and only hyperpolarised MRI contrast agent to be approved in the United States”, in February with the shares falling below 40p I concluded that the valuation and financial outlook in a still-challenging funding environment meant I certainly avoided. The shares most recently closed at 14.5p, and what of they currently at 11.5p on the back of half-year results?
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.
Filed under:
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Time left: 08:10:30